As noted above (see “statistical analysis”), self-assessment of blood glucose is recommended and payed for only for certain patient groups with diabetes (namely those with insulin treatment and those with other antidiabetic medication with hypoglycaemia potential or certain medical situations at risk for an instable metabolism). The gene discussed is INS; the disease is diabetes mellitus.